Application no. and date | 00946165.8 (espacenet) (Federated) (European Patent Register), 20000719 | Patent/reg. no. and date | DK/EP 1196170, 20040714 | Publication date | 20020417 | Priority no. and date | GB 9917158, 19990721 | EP pub. no. and date |
EP 1196170 20020417 | Effective date | | Applicant/owner | Astellas Pharma Inc., 2-5-1, Nihonbashi-Honcho Chuo-ku Tokyo 103-8411, JP | Applicant ref. no. | 36379 DK 01 | Inventor | JONES, Paul Alexander, University of Edinburgh
1 George Square
Edinburgh EH8 9JZ, GB, SHARKEY, John, University of Edinburgh
1 George Square
Edinburgh EH8 9JZ, GB, KELLY, John Shearer, University of Edinburgh
1 George Square
Edinburgh EH8 9JZ, GB | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/436 (2006.01) , A61P 25/00 (2006.01) , A61P 25/28 (2006.01) , A61P 9/10 (2006.01) | Title | Anvendelse af en makrolidforbindelse til fremstilling af et medikament til behandling af hjerneskade forårsaget af iskæmi eller blødning | Int. application no. | GB2000002788 | Int. publication no. | WO2001005385 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|